Insight Molecular Diagnostics Inc. (IMDX) vs Quantum Cyber N.V (QUCY)

Insight Molecular Diagnostics Inc. and Quantum Cyber N.V are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $129.3M against $113.4M — 1.1× the size. Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against −60.8%. Quantum Cyber N.V has the higher net margin (0.00% vs −2,955.6%) and the lower return on invested capital (−194.0% vs 0.00%). Across the 17 metrics below, Quantum Cyber N.V leads on 9 and Insight Molecular Diagnostics Inc. on 8.

Valuation

Metric IMDX QUCY Diagnostics & Research median
P/E n/m n/m 33.95
P/S 86.26 27.51 4.87
P/B n/m 1.21 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 75.74 14.34 5.66
Earnings yield (38.01%) (877.41%) (1.75%)
Free cash flow yield (21.52%) (67.39%) (0.13%)

Profitability

Metric IMDX QUCY Diagnostics & Research median
Gross margin 48.32% 56.91% 50.89%
Operating margin (3,011.86%) 0.00% (8.57%)
Net margin (2,955.63%) 0.00% (6.37%)
Free cash flow margin (1,856.23%) 0.00% 0.00%
Return on equity 488.68% (325.19%) (2.92%)
Return on assets (123.46%) (224.96%) (6.71%)
Return on invested capital 0.00% (193.99%) 0.00%

Growth

Metric IMDX QUCY Diagnostics & Research median
Revenue growth (TTM) (60.77%) 68.99% 7.69%
EPS growth (last fiscal year) 64.59% 87.92% —
Revenue growth, 5-year CAGR 27.24% 1.70% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX QUCY Diagnostics & Research median
Debt to equity (0.04) 0.00 0.11
Current ratio 2.00 5.56 2.02
Net debt to EBITDA (0.67) (0.01) 0.78

Dividend

Metric IMDX QUCY Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IMDX QUCY Diagnostics & Research median
Market cap 129.26m 113.36m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack